Peer Review History
| Original SubmissionJune 17, 2020 |
|---|
|
PONE-D-20-18639 Idiopathic and secondary restless legs syndrome during pregnancy in Japan: prevalence, clinical features and delivery-related outcomes PLOS ONE Dear Dr. Yoshimura, Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process. Please submit your revised manuscript by Oct 02 2020 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file. Please include the following items when submitting your revised manuscript:
If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter. If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: http://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols We look forward to receiving your revised manuscript. Kind regards, Antonio Simone Laganà, M.D., Ph.D. Academic Editor PLOS ONE Additional Editor Comments: The topic of the manuscript is interesting. Nevertheless, the reviewers raised several concerns: considering this point, I invite authors to perform the required major revisions. Journal Requirements: When submitting your revision, we need you to address these additional requirements. 1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and 2. Thank you for stating the following in the Financial Disclosure section: "This study was supported by Japan Society for the Promotion of Science KAKENHI Grant number 15K08737 and The Fukuoka University Internal Research Competitive Funds (Grant No.197006). CY and MF have grants for my institution from Fukuda Denshi and Fukuda Lifetec Kyushu. SA has grants for Kyushu University Hospital from Teijin Pharma, Philips Respironics, Fuji Zerox, Daiichi Sankyo, Astellas Pharma. CY received lecture fees from Fukuda Denshi, Fukuda Lifetec Kyushu, Pacific Medico, Philips Respironics, Daiichi Sankyo, Takeda, Otsuka. HA received lecture fees from Bayer, Daiichi Sankyo, Fukuda Denshi, MSD, Takeda, Teijin Pharma and fees for consultancy from Kyowa Kirin. SA received lecture fees from Teijin Pharma. The other of authors report no conflicts of interest. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript." We note that you received funding from commercial sources: Fukuda Denshi, Fukuda Lifetec Kyushu, Teijin Pharma, Philips Respironics, Fuji Zerox, Daiichi Sankyo, Astellas Pharma. Please provide an amended Competing Interests Statement that explicitly states these commercial funders, along with any other relevant declarations relating to employment, consultancy, patents, products in development, marketed products, etc. Within this Competing Interests Statement, please confirm that this does not alter your adherence to all PLOS ONE policies on sharing data and materials by including the following statement: "This does not alter our adherence to PLOS ONE policies on sharing data and materials.” (as detailed online in our guide for authors http://journals.plos.org/plosone/s/competing-interests). If there are restrictions on sharing of data and/or materials, please state these. Please note that we cannot proceed with consideration of your article until this information has been declared. Please include your amended Competing Interests Statement within your cover letter. We will change the online submission form on your behalf. Please know it is PLOS ONE policy for corresponding authors to declare, on behalf of all authors, all potential competing interests for the purposes of transparency. PLOS defines a competing interest as anything that interferes with, or could reasonably be perceived as interfering with, the full and objective presentation, peer review, editorial decision-making, or publication of research or non-research articles submitted to one of the journals. Competing interests can be financial or non-financial, professional, or personal. Competing interests can arise in relationship to an organization or another person. Please follow this link to our website for more details on competing interests: http://journals.plos.org/plosone/s/competing-interests [Note: HTML markup is below. Please do not edit.] Reviewers' comments: Reviewer's Responses to Questions Comments to the Author 1. Is the manuscript technically sound, and do the data support the conclusions? The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented. Reviewer #1: Partly Reviewer #2: Yes Reviewer #3: Partly ********** 2. Has the statistical analysis been performed appropriately and rigorously? Reviewer #1: Yes Reviewer #2: Yes Reviewer #3: No ********** 3. Have the authors made all data underlying the findings in their manuscript fully available? The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified. Reviewer #1: Yes Reviewer #2: Yes Reviewer #3: No ********** 4. Is the manuscript presented in an intelligible fashion and written in standard English? PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here. Reviewer #1: Yes Reviewer #2: Yes Reviewer #3: Yes ********** 5. Review Comments to the Author Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters) Reviewer #1: • This is a single center study titled ‘Idiopathic and secondary restless legs syndrome during pregnancy in Japan: prevalence, clinical features and delivery-related outcomes’ • The research was a prospective observational study. One hundred eighty-three consecutive pregnant women participated in the study from June 2014 to March 2016. • Participants were interviewed and examined in the second and third trimesters of pregnancy and 1 month after delivery. • RLS diagnosis was made on the diagnostic criteria of the International Restless Legs Syndrome Study Group (2010). My opinions and comments are as follows: Introduction: 1- Literature information on the subject was not given sufficiently 2- The hypothesis is not revealed clearly Methods: From June 2014 to March 2016, consecutive pregnant women (age ≥18 years) who visited the Amagase Obstetrics and Gynecology Clinic during the second trimester were invited to participate in the study. A total of 183 pregnant women who provided informed consent to the study were included. 1- The number of patients is insufficient for a prevalence study 2- From June 2014 to March 2016, how many consecutive pregnant women (age ≥18 years) applied to the Amagase Obstetrics and Gynecology Clinic and how many accepted to participate in the study? 3- International Classification fo Sleep Disorders was updated in 2014 as ICSD-3, and RLS diagnostic criteria was also updated as follows; RLS Diagnostic Criteria: Criteria A-C must be met A. An urge to move the legs, usually accompanied by or thought to be caused by uncomfortable and unpleasant sensations in the legs.1,2 These symptoms must: 1. Begin or worsen during periods of rest or inactivity such as lying down or sitting; 2. Be partially or totally relieved by movement, such as walking or stretching, at least as long as the activity continues; and 3. Occur exclusively or predominantly in the evening or night rather than during the day. B. The above features are not solely accounted for as symptoms of another medical or a behavioral condition (e.g., leg cramps, positional discomfort, myalgia, venous stasis, leg edema, arthritis, habitual foot tapping). C. The symptoms of RLS cause concern, distress, sleep disturbance, or impairment in mental, physical, social, occupational, educational, behavioral, or other important areas of functioning. 4- The authors should have used these criteria. At least leg cramps, positional discomfort, myalgia, venous stasis, leg edema, arthritis should have been questioned. Results and discussion: 1- Before pregnancy idiopathic RLS prevalence was 4.9%, but in the second trimester it decreased to 2.7% RLS, which existed before pregnancy in some pregnant women, appears to have improved in pregnancy Also secondary persistence was 0.6% in the second trimester RLS, which existed in the second trimester in some pregnant women, appears to have improved in the third trimester These rates have not been examined separately 2- Secondary persistance in the third trimester and postpartum seems the same (0.6%), this situation has not been discussed either 3- New diagnosed diseases during pregnancy; like gestational DM and preeclampsia was not questioned 4- Relation between maternal age, weight and additional diseases with RLS have not been investigated Reviewer #2: The authors should be applauded for their work describing RLS during pregnancy in Japan. This is an important topic that is often overlooked, possibly because it falls between two specialties (sleep medicine/neurology and obstetrics). I have several questions regarding the manuscript as well as some thoughts on how it may be improved. Major concerns: I am confused as to the trajectory of RLS symptoms in this cohort. Based on the results section as well as table 3 and Figure one it appears that the following is true: 1) The prevalence of RLS in young women in Japan is around 5%. This seems plausible. 2) During the 2nd trimester the prevalence actually drops. While some new cases arise these are more than offset by the apparent resolution of some of the idiopathic cases. 3) By the 3rd trimester everyone who had RLS before pregnancy no longer has RLS, ie the RLS has resolved. Others have developed RLS during the pregnancy which keeps the prevalence around 5% 4) Following delivery almost all of the RLS resolves. The prevalence is now very low and no one who had RLS prior to pregnancy had a return of symptoms. In most cases pregnancy exacerbates pre-existing RLS. In fact pre-pregnancy RLS is the strongest predictor of pregnancy related RLS (https://doi.org/10.1016/j.sleep.2008.06.011) However, these finding suggest that pregnancy improves RLS symptoms to the same degree that it causes it. This finding could be due to several different possibilities. A) I am misinterpreting the data, in which case further explanation would be appreciated B) RLS did improve for many of the subjects, which if is the case the authors should elaborate on this in detail including reasons for why they think this could be the case. C) There is a methodological problem such as not asking about RLS symptoms at subsequent visits or having an imprecise diagnostic tool. Minor concerns: 1) The wording of the methods section of abstract gives the impression that a sleep medicine specialist evaluated each subject during each visit. The wording of the methods section itself gives the impression that a research assistant asked a series of questions based IRLSSG / ICSD-3 criteria and then a sleep medicine specialist reviewed the results at a later time. This should clarified. 2) It would be beneficial to briefly discuss the role of iron in the RLS as the authors mention that being on iron supplements may have affected their results. 3) For the Suzuki 2003 paper the estimated prevalence of RLS during pregnancy in Japan was based off on a single question and not the four criteria that the authors of this study used. The authors mention this but should elaborate further as it could help to explain the much higher prevalence that the Suzuki 2003 paper reports. 4) Was there a certain time of day that the labs were drawn? Serum iron levels have strong circadian fluctuations. (https://doi.org/10.1016/j.clinbiochem.2010.08.023) 5) Other papers which may add to the manuscript. https://doi.org/10.1016/j.sleep.2009.04.005 https://doi.org/10.1016/j.genhosppsych.2009.11.016 https://doi.org/10.5664/jcsm.3704 https://doi.org/10.1016/j.smrv.2014.10.009 Reviewer #3: I was pleased to revise the manuscript entitled “Idiopathic and secondary restless legs syndrome during pregnancy in Japan: prevalence, clinical features and delivery-related outcomes” (Manuscript Number: PONE-D-20-18639). This study was approved by the Ethics Committee of Kyushu University Hospital and written informed consent was obtained from all participants before enrolment. In general, this manuscript was aimed to investigate prevalence of idiopathic and secondary restless legs syndrome (RLS) according to pregnancy trimester, and its effects on delivery-related outcomes among pregnant women in Japan. In my honest opinion, the topic is interesting enough to attract the readers’ attention. Methodology is accurate and conclusions are supported by the data analysis. Nevertheless, authors should clarify some points. In general, the Manuscript may benefit from some major revisions, as suggested below: - All the text needs a language revision in order to improve some typos and grammatical errors. - I would suggest checking the guidelines for the Authors to conform the manuscript. In example, the results section needs to be reported before the methods. - Methods. I would suggest providing more details about the recruitment of patients. Which was the use modality? Which proportion of the actual total population referring to the hospital was included? Which is the response rate? Are characteristics of non-responders available or at least reason to non-participate? Which information was provided to the patients for recruitment? These pieces of information are paramount to identify possible biases. - At which gestational age was the recruitment allowed? - When the idiopathic RLS was assessed? How was it actually defined? Before pregnancy or before a certain gestational age? - Which was the frequency of obstetrics visits? Was it the same for all patients? - Discussion. Possible biases, such as non-responder bias, attrition bias, and referral bias need to be discussed. The association between cesarean section and RLS could be related to the fact that patients with obstetric pathologies underwent an higher number of obstetrics evaluation with higher chance of RLS diagnosis. - How would the authors interpret the disappearing of idiopathic RLS? Was it assessed only once during pregnancy? It is unclear how a condition present before pregnancy is no more reported later in pregnancy. - The observed association between RLS and cesarean section is interesting, and I would suggest, at least briefly, stressing more complications related to cesarean section, such as bladder injuries (refer to: PMID: 30877907), to stress the importance to reduce cesarean section rate. - Did the authors include in the analysis possible other background pathologies, such as endometriosis, or gestational diabetes? In this regard, I would suggest discussing about other possible obstetrics complications that could be investigated in terms of association with RLS. Refer to: PMID: 31903997; DOI: 10.1007/s10397-015-0901-9; PMID: 32046116. ********** 6. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy. Reviewer #1: No Reviewer #2: No Reviewer #3: No [NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.] While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step. |
| Revision 1 |
|
PONE-D-20-18639R1 Idiopathic and secondary restless legs syndrome during pregnancy in Japan: prevalence, clinical features and delivery-related outcomes PLOS ONE Dear Dr. Yoshimura, Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process. Please submit your revised manuscript by Apr 22 2021 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file. Please include the following items when submitting your revised manuscript:
If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter. If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: http://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols We look forward to receiving your revised manuscript. Kind regards, Antonio Simone Laganà, M.D., Ph.D. Academic Editor PLOS ONE Journal Requirements: Please review your reference list to ensure that it is complete and correct. If you have cited papers that have been retracted, please include the rationale for doing so in the manuscript text, or remove these references and replace them with relevant current references. Any changes to the reference list should be mentioned in the rebuttal letter that accompanies your revised manuscript. If you need to cite a retracted article, indicate the article’s retracted status in the References list and also include a citation and full reference for the retraction notice. Additional Editor Comments (if provided): Authors improved significantly the quality of the paper, following the recommendations of the Reviewers. Nevertheless, one of them still has some concerns: for this reason, I invite authors to perform additional minor revisions. [Note: HTML markup is below. Please do not edit.] Reviewers' comments: Reviewer's Responses to Questions Comments to the Author 1. If the authors have adequately addressed your comments raised in a previous round of review and you feel that this manuscript is now acceptable for publication, you may indicate that here to bypass the “Comments to the Author” section, enter your conflict of interest statement in the “Confidential to Editor” section, and submit your "Accept" recommendation. Reviewer #2: (No Response) Reviewer #3: All comments have been addressed ********** 2. Is the manuscript technically sound, and do the data support the conclusions? The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented. Reviewer #2: Partly Reviewer #3: Yes ********** 3. Has the statistical analysis been performed appropriately and rigorously? Reviewer #2: I Don't Know Reviewer #3: Yes ********** 4. Have the authors made all data underlying the findings in their manuscript fully available? The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified. Reviewer #2: Yes Reviewer #3: Yes ********** 5. Is the manuscript presented in an intelligible fashion and written in standard English? PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here. Reviewer #2: Yes Reviewer #3: Yes ********** 6. Review Comments to the Author Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters) Reviewer #2: Thank you for the revisions. In response to my primary question about the study, the authors state that "RLS did improve for many of the subjects in our study." However that under-emphasizes this finding and perhaps misses the point I was trying to make. While some studies have reported improvement in RLS symptoms during pregnancy for a minority of subjects with pre-existing RLS (11% on systemic review doi:10.1186/s12883-020-01709-0), to my knowledge none have reported complete resolution of RLS in such large number of cases. Not only did RLS improve for some of the subjects in this study, 100% of the subjects with RLS prior to pregnancy had resolution of RLS by the third trimester. This fact is still not adequately discussed by the authors, particularly as it varies so much from established literature. The statement re: the role of iron in RLS is simplistic and lacking a citation. The thought that use of iron supplements may account for some of the improvement in symptoms is reasonable, though that this may explain the large difference between the prevalence of this study and others is unconvincing as most countries have similar recommendations. The description of RLS is also somewhat odd "Restless legs syndrome (RLS) is a sleep disorder(6) (7), which is characterized by an unpleasant and itchy dysesthesia of the legs that begin after rest and is relieved with movement during pregnancy." Itchiness is not necessarily present and the wording sounds as if RLS is specific to pregnancy. Reviewer #3: I was pleased to revise the manuscript entitled “Idiopathic and secondary restless legs syndrome during pregnancy in Japan: prevalence, clinical features and delivery-related outcomes” (Manuscript Number: PONE-D-20-18639). This study was approved by the Ethics Committee of Kyushu University Hospital and written informed consent was obtained from all participants before enrolment. In general, this manuscript was aimed to investigate prevalence of idiopathic and secondary restless legs syndrome (RLS) according to pregnancy trimester, and its effects on delivery-related outcomes among pregnant women in Japan. In my honest opinion, the topic is interesting enough to attract the readers’ attention. Methodology is accurate and conclusions are supported by the data analysis. Moreover, the authors addressed all the suggested revisions, and I appreciated the manuscript improvement. ********** 7. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy. Reviewer #2: No Reviewer #3: No [NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.] While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step. |
| Revision 2 |
|
Idiopathic and secondary restless legs syndrome during pregnancy in Japan: prevalence, clinical features and delivery-related outcomes PONE-D-20-18639R2 Dear Dr. Yoshimura, We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements. Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication. An invoice for payment will follow shortly after the formal acceptance. To ensure an efficient process, please log into Editorial Manager at http://www.editorialmanager.com/pone/, click the 'Update My Information' link at the top of the page, and double check that your user information is up-to-date. If you have any billing related questions, please contact our Author Billing department directly at authorbilling@plos.org. If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org. Kind regards, Antonio Simone Laganà, M.D., Ph.D. Academic Editor PLOS ONE Additional Editor Comments (optional): Authors performed the required corrections. I am pleased to accept this paper for publication. Reviewers' comments: |
| Formally Accepted |
|
PONE-D-20-18639R2 Idiopathic and secondary restless legs syndrome during pregnancy in Japan: prevalence, clinical features and delivery-related outcomes Dear Dr. Yoshimura: I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now with our production department. If your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information please contact onepress@plos.org. If we can help with anything else, please email us at plosone@plos.org. Thank you for submitting your work to PLOS ONE and supporting open access. Kind regards, PLOS ONE Editorial Office Staff on behalf of Dr. Antonio Simone Laganà Academic Editor PLOS ONE |
Open letter on the publication of peer review reports
PLOS recognizes the benefits of transparency in the peer review process. Therefore, we enable the publication of all of the content of peer review and author responses alongside final, published articles. Reviewers remain anonymous, unless they choose to reveal their names.
We encourage other journals to join us in this initiative. We hope that our action inspires the community, including researchers, research funders, and research institutions, to recognize the benefits of published peer review reports for all parts of the research system.
Learn more at ASAPbio .